This article was originally published in IP Watch.
Brief: Europe Medicines Group Joins Initiative To Fight Fake Medicines
27/05/2016 BY INTELLECTUAL PROPERTY WATCH
Medicines for Europe, representing the generic, biosimilar, and medicines in Europe, announced today during a side event at the World Health Assembly, that it joined the Global Campaign to Fight Fake Medicines.
Medicines for Europe said in a release that it “acknowledges the magnitude of the problem related to the existence and spread of fake medicines.”
Fight the Fakes campaign “represents a great opportunity for a multi-stakeholder and multi-disciplinary collaboration,” said Adrian van den Hoven, Medicines for Europe director general. He also highlighted the fact that fake medicines are “illegal and dangerous.”
According to the release, fake medicines can be branded or generic, prescription or over-the-counter medicines.
